Hubert Birner
CIK 1398598 · last filed 2018-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$58.82M
Companies
5
Total Filings
19
Lifetime Open-Market Net
-$157.08M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PRTO | Director | 1,903,127 | $27.53 | $52.39M | $3.00M | 6 | 2018-06-11 |
| ARGOS THERAPEUTICS INC (ARGS) Delisted | Director | 1,943,013 | — | — | $319.0K | 10 | 2017-01-20 |
| ENTA | 10%+ Owner | 459,064 | $14.00 | $6.43M | -$170.53M | 1 | 2014-03-07 |
| CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | 10%+ Owner | 1,245,736 | $8.37 | $10.43M | $8.72M | 1 | 2014-02-20 |
| Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Director | 409,116 | $116.30 | $47.58M | $1.41M | 1 | 2011-08-04 |
Recent Filings · Page 2 of 2
19 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-04-04 | ARGOS THERAPEUTICS INC (ARGS) Delisted | Grant (A) | +2,734 | $0 | EDGAR |
| 2016-03-16 | ARGOS THERAPEUTICS INC (ARGS) Delisted | Buy (P) | +183,697 | $0 | EDGAR |
| 2015-06-19 | ARGOS THERAPEUTICS INC (ARGS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-06-03 | PRTO | Grant (A) | — | $0 | EDGAR |
| 2014-10-30 | PRTO | Mixed | +1,943,059 | $3.72M | EDGAR |
| 2014-03-07 | ENTA | Sell (S) | −4,393,340 | -$170.53M | EDGAR |
| 2014-02-20 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Mixed | +10,014,025 | $8.72M | EDGAR |
| 2014-02-12 | ARGOS THERAPEUTICS INC (ARGS) Delisted | Mixed | +1,471,091 | $319.0K | EDGAR |
| 2011-08-04 | Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Mixed | +899,951 | $2.54M | EDGAR |
Showing 11–19 of 19
Prev
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.